C000010386 Holdings — Health Care Fund
All 134 reported holdings of Health Care Fund (C000010386) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Company | 4.34% | $456.98K |
| Johnson & Johnson | 3.45% | $362.92K |
| Abbvie, Inc. | 3.01% | $317.32K |
| Unitedhealth Group, Inc. | 2.66% | $279.72K |
| Merck & Company, Inc. | 2.44% | $257.00K |
| Thermo Fisher Scientific, Inc. | 1.92% | $202.05K |
| Amgen, Inc. | 1.86% | $196.27K |
| Abbott Laboratories | 1.69% | $178.39K |
| Gilead Sciences, Inc. | 1.66% | $174.73K |
| Vertex Pharmaceuticals, Inc. | 1.59% | $167.89K |
| Cvs Health Corp. | 1.57% | $165.11K |
| Intuitive Surgical, Inc. | 1.56% | $164.64K |
| Danaher Corp. | 1.56% | $163.81K |
| Pfizer, Inc. | 1.50% | $157.58K |
| Bristol-Myers Squibb Company | 1.46% | $153.33K |
| Stryker Corp. | 1.45% | $152.38K |
| Mckesson Corp. | 1.26% | $132.23K |
| Elevance Health, Inc. | 1.22% | $128.78K |
| Cigna Group (the) | 1.12% | $117.72K |
| Regeneron Pharmaceuticals, Inc. | 1.08% | $113.48K |
| Hca Healthcare, Inc. | 1.04% | $109.95K |
| Cardinal Health, Inc. | 1.03% | $108.09K |
| Boston Scientific Corp. | 1.03% | $108.02K |
| Edwards Lifesciences Corp. | 1.00% | $105.20K |
| Novo Nordisk A/s | 0.99% | $104.17K |
| Cencora, Inc. | 0.98% | $103.00K |
| Humana, Inc. | 0.96% | $101.29K |
| Medtronic PLC | 0.93% | $97.63K |
| Natera, Inc. | 0.92% | $97.18K |
| Revolution Medicines, Inc. | 0.91% | $96.26K |
| Becton Dickinson & Company | 0.89% | $93.52K |
| Icon PLC | 0.88% | $92.59K |
| Alnylam Pharmaceuticals, Inc. | 0.87% | $91.51K |
| Agilent Technologies, Inc. | 0.85% | $89.66K |
| Waters Corp. | 0.84% | $88.88K |
| Idexx Laboratories, Inc. | 0.83% | $87.92K |
| Argenx SE | 0.83% | $87.21K |
| Beone Medicines Ltd. | 0.80% | $84.35K |
| Jazz Pharmaceuticals PLC | 0.80% | $84.10K |
| Iqvia Holdings, Inc. | 0.79% | $83.47K |
| Moderna, Inc. | 0.79% | $83.48K |
| Biogen, Inc. | 0.78% | $82.53K |
| Centene Corp. | 0.78% | $81.65K |
| Alkermes PLC | 0.77% | $81.58K |
| Royalty Pharma PLC | 0.74% | $78.22K |
| Mettler-Toledo International, Inc. | 0.73% | $76.65K |
| Ge Healthcare Technologies, Inc. | 0.73% | $76.43K |
| Veeva Systems, Inc. | 0.72% | $76.31K |
| Resmed, Inc. | 0.72% | $75.81K |
| Astrazeneca PLC | 0.71% | $75.09K |
| Illumina, Inc. | 0.71% | $75.08K |
| West Pharmaceutical Services, Inc. | 0.71% | $74.67K |
| Teva Pharmaceutical Industries Ltd. | 0.71% | $74.47K |
| Gsk PLC | 0.70% | $73.86K |
| Crispr Therapeutics AG | 0.69% | $72.59K |
| Biontech SE | 0.69% | $72.21K |
| Quest Diagnostics, Inc. | 0.67% | $70.37K |
| Labcorp Holdings, Inc. | 0.67% | $70.28K |
| Novartis AG | 0.66% | $69.90K |
| Zoetis, Inc. | 0.66% | $69.85K |
| Insmed, Inc. | 0.66% | $69.62K |
| Dexcom, Inc. | 0.65% | $68.43K |
| United Therapeutics Corp. | 0.64% | $67.19K |
| Guardant Health, Inc. | 0.63% | $66.76K |
| Ascendis Pharma A/s | 0.63% | $66.68K |
| Alcon AG | 0.62% | $65.36K |
| Steris PLC | 0.62% | $64.86K |
| Roivant Sciences Ltd. | 0.61% | $64.48K |
| Incyte Corp. | 0.60% | $62.91K |
| Viatris, Inc. | 0.57% | $60.34K |
| Neurocrine Biosciences, Inc. | 0.56% | $59.16K |
| Zimmer Biomet Holdings, Inc. | 0.55% | $57.85K |
| Tenet Healthcare Corp. | 0.55% | $57.62K |
| Cooper Companies, Inc. (the) | 0.52% | $54.86K |
| Molina Healthcare, Inc. | 0.51% | $54.20K |
| Bio-Techne Corp. | 0.51% | $53.98K |
| Bridgebio Pharma, Inc. | 0.51% | $53.77K |
| Ionis Pharmaceuticals, Inc. | 0.50% | $52.57K |
| Cytokinetics, Inc. | 0.50% | $52.48K |
| Revvity, Inc. | 0.50% | $52.29K |
| Exelixis, Inc. | 0.49% | $51.69K |
| Charles River Laboratories International, Inc. | 0.49% | $51.48K |
| Elanco Animal Health, Inc. | 0.47% | $49.69K |
| Medpace Holdings, Inc. | 0.46% | $48.72K |
| Arrowhead Pharmaceuticals, Inc. | 0.46% | $48.58K |
| Biomarin Pharmaceutical, Inc. | 0.46% | $48.18K |
| Align Technology, Inc. | 0.45% | $47.90K |
| Baxter International, Inc. | 0.45% | $47.91K |
| Insulet Corp. | 0.44% | $46.59K |
| Ensign Group, Inc. (the) | 0.43% | $45.69K |
| Halozyme Therapeutics, Inc. | 0.43% | $45.55K |
| Vaxcyte, Inc. | 0.43% | $44.93K |
| Axsome Therapeutics, Inc. | 0.42% | $44.30K |
| Krystal Biotech, Inc. | 0.42% | $43.86K |
| J.p. Morgan Securities LLC | 0.41% | $43.23K |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 0.41% | $43.23K |
| Hims & Hers Health, Inc. | 0.40% | $42.54K |
| Tg Therapeutics, Inc. | 0.40% | $42.14K |
| Universal Health Services, Inc. | 0.40% | $41.78K |
| Henry Schein, Inc. | 0.39% | $41.26K |
| Protagonist Therapeutics, Inc. | 0.39% | $41.06K |
| Corcept Therapeutics, Inc. | 0.39% | $40.69K |
| Tempus Ai, Inc. | 0.38% | $40.03K |
| Healthequity, Inc. | 0.37% | $39.29K |
| Repligen Corp. | 0.37% | $38.75K |
| Lantheus Holdings, Inc. | 0.37% | $38.61K |
| Ptc Therapeutics, Inc. | 0.36% | $38.26K |
| Scholar Rock Holding Corp. | 0.36% | $38.23K |
| Madrigal Pharmaceuticals, Inc. | 0.36% | $37.59K |
| Avantor, Inc. | 0.36% | $37.43K |
| Bruker Corp. | 0.35% | $37.31K |
| Mirum Pharmaceuticals, Inc. | 0.33% | $35.00K |
| Viking Therapeutics, Inc. | 0.33% | $34.84K |
| Praxis Precision Medicines, Inc. | 0.32% | $34.15K |
| Rhythm Pharmaceuticals, Inc. | 0.32% | $33.86K |
| Indivior Pharmaceuticals, Inc. | 0.31% | $32.82K |
| Alignment Healthcare, Inc. | 0.30% | $31.86K |
| Radnet, Inc. | 0.29% | $30.28K |
| Ultragenyx Pharmaceutical, Inc. | 0.28% | $29.95K |
| Merit Medical Systems, Inc. | 0.28% | $29.26K |
| Acadia Pharmaceuticals, Inc. | 0.26% | $27.70K |
| Option Care Health, Inc. | 0.25% | $26.11K |
| Acadia Healthcare Company, Inc. | 0.24% | $24.86K |
| Waystar Holding Corp. | 0.22% | $23.53K |
| Recursion Pharmaceuticals, Inc. | 0.20% | $21.27K |
| Dentsply Sirona, Inc. | 0.20% | $21.10K |
| Sarepta Therapeutics, Inc. | 0.20% | $21.10K |
| Summit Therapeutics, Inc. | 0.20% | $20.66K |
| Transmedics Group, Inc. | 0.19% | $19.86K |
| Adma Biologics, Inc. | 0.19% | $19.55K |
| Irhythm Holdings, Inc. | 0.15% | $16.30K |
| Genedx Holdings Corp. | 0.14% | $14.97K |
| Jnj Cvr | 0.00% | $0 |
| Sanofi SA - Cvr | 0.00% | $0 |
C000010386 overview: performance, fees, allocation and SEC filings